Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome

Neurogastroenterology and Motility

Volumn 22, Issue 5, 2010, Pages

  Tana, C ^a   Umesaki, Y ^b   Imaoka, A ^b   Handa, T ^a   Kanazawa, M ^a   Fukudo, S ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

Acetic acid; Gastrointestinal (GI) microbiota; Irritable bowel syndrome (IBS); Lactobacillus; Propionic acid; Veillonella

Indexed keywords

ACETIC ACID; CARBOXYLIC ACID; PROPIONIC ACID;

ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; BACTERIUM CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; EMOTION; FECES ANALYSIS; FEMALE; GASTROINTESTINAL SYMPTOM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMAGE ANALYSIS; INTESTINE FLORA; IRRITABLE COLON; LACTOBACILLUS; MALE; NONHUMAN; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; REAL TIME POLYMERASE CHAIN REACTION; VEILLONELLA;

ACETIC ACID; ADULT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA, BACTERIAL; FECES; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IRRITABLE BOWEL SYNDROME; LACTOBACILLUS; MALE; METAGENOME; PROPIONIC ACIDS; QUALITY OF LIFE; QUESTIONNAIRES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; VEILLONELLA;

EID: 77950670562     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2009.01427.x     Document Type: Article

References (45)

1. Chang L, Toner BB, Fukudo S et al. Gender, age, society, culture, and the patient's perspective in the functional gastrointestinal disorders. Gastroenterology 2006 130 : 1435 1446.
2. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006 130 : 1480 1491.
3. Gralnek IM, Hays RD, Kilbourne AM et al. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology 2000 119 : 654 660.
4. Fukudo S, Nomura T, Muranaka M, Taguchi F. Brain-gut response to stress and cholinergic stimulation in irritable bowel syndrome. A preliminary study. J Clin Gastroenterol 1993 17 : 133 141.
5. Barbara G, De Giorgio R, Stanghellini V et al. A role for inflammation in irritable bowel syndrome? Gut 2002 51 (Suppl. 1 i41 4.
6. Sonnenburg JL, Angenent LT, Gordon JI. Getting a grip on things: how do communities of bacterial symbionts become established in our intestine? Nat Immun 2004 5 : 569 573.
7. Spiller RC. Postinfectious irritable bowel syndrome. Gastroenterology 2003 124 : 1662 1671.
8. Verdú EF, Bercik P, Verma-Gandhu M et al. Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice. Gut 2006 55 : 182 190.
9. O'Mahony L, McCarthy J, Kelly P et al. Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relational to cytokine profiles. Gastroenterology 2005 128 : 541 551.
10. Rousseaux C, Thuru X, Gelot A et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 2007 13 : 35 7.
11. Malinen E, Rinttilä T, Kajander K et al. Analysis of the microbiota of irritable bowel syndrome patients and healthy controls with real-time PCR. Am J Gastroenterol 2005 100 : 373 382.
12. Kassinen A, Kroqius-Kurikka L, Mökivuokko H et al. The feacal microbiota of irritable bowel syndrome patients differs significantly from that of health subjects. Gastroenterology 2007 133 : 24 33.
13. Franks AH, Harmsen HJ, Raangs GC et al. Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S r RNA-targeted oligonucleotide probes. Appl Environ Microbiol 1998 64 : 3336 3345.
14. Koide A, Yamaguchi T, Odaka T et al. Quantitative analysis of bowel gas using plain abdominal radiograph in patients with irritable bowel syndrome. Am J Gastroenterol 2000 95 : 1735 1741.
15. Mortensen PB, Andersen JR, Arffmann S et al. Short-chain fatty acids and the irritable bowel syndrome: the effect of wheat bran. Scand J Gastroenterol 1987 22 : 185 192.
16. Treem WR, Ahsan N, Kastoff G et al. Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation. J Pediatr Gastroenterol Nutr 1996 23 : 280 286.
17. Tompson WG, Longstreth GF, Drossman DA et al. Functional bowel disorders and functional abdominal pain. Gut 1999 45 (Suppl. 2 II43 7.
18. Drossman DA, Talley NJ, Whitehead WE, et al. Research diagnostic questions for functional gastrointestinal disorders: Rome II modular questionnaire: investigations and respondent forms. In : Drossman DA, Corazziari E, Talley NJ, Thompson WG, eds. Rome II: The Functional Gastrointestinal Disorders, 2nd edn.
19. Matsumoto K, Takada T, Shimizu K et al. The effects of a probiotic milk product containing Lactobacillus casei strain Shirota on the defecation frequency and the intestinal microbiota of sub-optimal health state volunteers: a randomized placebo-controlled cross-over study. Biosci Micobiota 2006 25 : 39 48.
20. Brigidi P, Vitali B, Swennen E et al. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea. Res Microbiol 2001 152 : 735 741.
21. Matsuki T, Watanabe K, Fujimoto J et al. Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl Environ Microbiol 2004 70 : 7220 7228.
22. Matsuki T, Fujimoto J, Watanabe K. Group-specific PCR primers for the detection of human intestinal bacteria. Japanese patent 2007-20423.
23. Matsuki T, Watanabe K, Fujimoto J et al. Development of 16S rRNA-gene-targeted group-specific primers for the detection and identification of predominant bacteria in human feces. Appl Environ Microbiol 2002 68 : 5445 5451.
24. Kikuchi H, Tajima T. Correlation between water-holding capacity of different types of cellulose in vitro and gastrointestinal retention time in vivo of rats. J Sci Agric 1992 60 : 139 146.
25. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997 11 : 395 402.
26. Svedlund J, Sjödin I, Dotevall G. GSRS - a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988 33 : 129 134.
27. Shinozaki M, Fukudo S, Hongo M et al. High prevalence of irritable bowel syndrome in medical out-patients in Japan. J Clin Gastroenterol 2008 42 : 1010 1016.
28. Drossman DA, Patrick DL, Whitehead WE et al. Futher validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol 2000 95 : 999 1007.
29. Ware JE Jr., Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992 30 : 473 483.
30. Zung WW. A self-rating depression scale. Arch Gen Psychiatry 1965 12 : 63 70.
31. Speilberger CD, Gorsuch RL, Lushene RE. STAI Manual.
32. Cohen S, Tyrrell DA, Smith AP. Psychological stress and susceptibility to the common cold. N Engl J Med 1991 325 : 606 612.
33. Bagby RM, Parker JD, Taylor GJ. The twenty-item Toronto Alexithymia Scale - I. Item selection and cross-validation of the factor structure. J Psychosom Res 1994 38 : 23 32.
34. Taylor GJ. Recent developments in alexithymia theory and research. Can J Psychiatry 2000 45 : 134 142.
35. Hoverstad T, Bjornaklett A, Fausa O et al. Short-chain fatty acids in the small-bowel bacterial overgrowth syndrome. Scand J Gastroenterol 1985 20 : 492 499.
36. Hoverstad T, Carlstedt-Duke B, Lingaas E et al. Influence of oral intake of seven different antibiotics on faecal short-chain fatty acid excretion in health subjects. Scand J Gastroenterol 1986 21 : 997 1003.
37. Hegazi FZ, Abo-Elinaga IG. Degradation of organic acids by dairy lactic acid bacteria. Zentralbl Bakteriol Naturwiss 1980 135 : 212 222.
38. Durant JA, Nisbet DJ, Ricke SC. Comparison of batch culture growth and fermentation of a poultry Veillonella isolate and selected Veillonella species groen in a defined medium. Anaerobe 1997 3 : 391 397.
39. Aerssens J, Hillsley K, Peeters PJ et al. Alteration in the brain-gut axis underlying visceral hypersensitivity in Nippostrongylus brasilinensis-infected mice. Gastroenterology 2007 132 : 1375 1387.
40. Tominaga M, Julius D. Capsaicin receptor in the pain pathway. Jpn J Pharmacol 2000 83 : 20 4.
41. Winston J, Shenoy M, Medley D et al. The vanilloid receptor initiates and maintains colonic hypersensitivity induced by neonatal colon irritation in rats. Gastroenterology 2007 132 : 615 627.
42. Chan CLH, Facer P, Davis JB et al. Sensory fibres expressing capsaicin receptor TRPV1 in patients with rectal hypersensitivity and feacal urgency. Lancet 2003 361 : 385 391.
43. Brierley SM, Hughes PA, Page AJ et al. Novel and specific roles for the inon channel TRPA1 in visceral sensory transduction. Gastroenterology 2008 134 (Suppl. 1 A8.
44. Michl T, Jocic M, Heinemann A et al. Vagal afferent signaling of a gastric mucosal acid insult to medullary, pontine, thalamic, hypothalamic and limbic, but not cortical, nuclei of the rat brain. Pain 2001 92 : 19 27.
45. Drossman DA, Morris CB, Hu Y et al. A prospective assessment of bowel habit in irritable bowel syndrome in women: defining an alternator. Gastroenterology 2005 128 : 580 589.